These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15069436)

  • 21. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus retinitis in an immunocompromised infant: a case report and review of the literature.
    Mota A; Breda J; Silva R; Magalhães A; Falcão-Reis F
    Case Rep Ophthalmol; 2011 May; 2(2):238-42. PubMed ID: 21941498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress in the studies on cytomegalovirus retinitis].
    Li HY; Ye JJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):223-7. PubMed ID: 12905727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ophthalmic manifestation of aids in Armed Forces General Teaching Hospital, Addis Ababa.
    T/Giorgis A; Melka F; G/Mariam A
    Ethiop Med J; 2007 Oct; 45(4):327-34. PubMed ID: 18326342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMV retinitis and dementia in an Indian with AIDS.
    Lehl SS; Bambery P; Avasthi A; Dogra MR; Deodhar SD
    J Assoc Physicians India; 1995 Feb; 43(2):136-7. PubMed ID: 9282683
    [No Abstract]   [Full Text] [Related]  

  • 26. Yellow-white retinal lesion in a 48-year-old woman. Cytomegalovirus (CMV) retinitis.
    Lai WW
    Am Fam Physician; 2007 Aug; 76(4):565-6. PubMed ID: 17853632
    [No Abstract]   [Full Text] [Related]  

  • 27. A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
    Borucki MJ; Spritzler J; Asmuth DM; Gnann J; Hirsch MS; Nokta M; Aweeka F; Nadler PI; Sattler F; Alston B; Nevin TT; Owens S; Waterman K; Hubbard L; Caliendo A; Pollard RB;
    Antiviral Res; 2004 Nov; 64(2):103-11. PubMed ID: 15498605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juxtapapillary cytomegalovirus retinitis with optic neuritis.
    Ioannidis AS; Bacon J; Frith P
    J Neuroophthalmol; 2008 Jun; 28(2):128-30. PubMed ID: 18562846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
    Martin BK; Ricks MO; Forman MS; Jabs DA;
    Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.
    Choi YL; Kim JA; Jang KT; Kim DS; Kim WS; Lee JH; Yang JM; Lee ES; Lee DY
    Br J Dermatol; 2006 Nov; 155(5):977-82. PubMed ID: 17034528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of cotton-wool spots is predictive for the development of CMV retinitis.
    Morlat P; Chêne G; Vimard E; Dumas B; Ragnaud JM; Beylot J
    Int J STD AIDS; 1998 Feb; 9(2):122-3. PubMed ID: 9506381
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytomegalovirus retinitis in patients with AIDS: current status.
    Nichols TT
    Med J Aust; 1996 Apr; 164(7):446. PubMed ID: 8609866
    [No Abstract]   [Full Text] [Related]  

  • 33. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
    Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of Cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome and efficacy of the current therapy.
    Zhao Q; Li NN; Chen YX; Zhao XY
    Front Cell Infect Microbiol; 2023; 13():1107237. PubMed ID: 37305416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial comment: failure of HAART to reconstitute CMV-specific protective immunity.
    Jacobson MA
    AIDS Read; 2005 Apr; 15(4):188. PubMed ID: 15844239
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation.
    Xhaard A; Robin M; Scieux C; de Latour RP; Deplus S; Mazeron MC; Devergie A; Espérou H; Rocha V; Gluckman E; Ribaud P; Socié G
    Transplantation; 2007 Jan; 83(1):80-3. PubMed ID: 17220797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation.
    Scherger SJ; Molina KC; Palestine AG; Pecen PE; Bajrovic V
    Transplant Proc; 2024 Sep; 56(7):1696-1701. PubMed ID: 39147617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir.
    Ausayakhun S; Yuvaves P; Ngamtiphakom S; Prasitsilp J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S15-20. PubMed ID: 16681046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The high-dose, alternate-week intravitreal ganciclovir injections for cytomegalovirus retinitis in acquired immune deficiency syndrome patients on highly active antiretroviral therapy.
    Yutthitham K; Ruamviboonsuk P
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S63-8. PubMed ID: 16681054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinician versus reading center assessment of cytomegalovirus retinitis lesion size.
    Weinberg DV; Holbrook JT; Hubbard LD; Davis MD; Jabs DA; Holland GN;
    Ophthalmology; 2005 Apr; 112(4):559-66. PubMed ID: 15808244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.